BOSTON SCIENTIFIC CORPORATION Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
BOSTON SCIENTIFIC CORPORATION (BSX) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $3.00 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-29.
Discontinued › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2018-10-29
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2018-09-30 was $3.00M, a 78.57% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2018-06-30 was $2.00M, a 84.62% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2017-09-30 was $14.00M.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2017-06-30 was $13.00M.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, income tax penalties and interest expense for fiscal 2010 was $14.00M, a 54.84% decline from fiscal 2009.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, income tax penalties and interest expense for fiscal 2009 was $31.00M, a 675.00% increase from fiscal 2008.
- BOSTON SCIENTIFIC CORPORATION unrecognized tax benefits, income tax penalties and interest expense for fiscal 2008 was $4.00M.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 9 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|---|---|---|
| 2018-09-30 | $3.00M 10-Q · filed 2018-10-29 | $5.00M derived: sum of 2 quarters · filed 2018-10-29 | $22.00M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $2.00M 10-Q · filed 2018-07-31 | $19.00M 10-Q · filed 2018-07-31 | ||
| 2017-09-30 | $14.00M 10-Q · filed 2018-10-29 | $27.00M derived: sum of 2 quarters · filed 2018-10-29 | $40.00M 10-Q · filed 2018-10-29 | |
| 2017-06-30 | $13.00M 10-Q · filed 2018-07-31 | $26.00M 10-Q · filed 2018-07-31 | ||
| 2011-03-31 | $7.00M 10-Q · filed 2011-05-05 | |||
| 2010-12-31 | $14.00M 10-K · filed 2011-02-17 | |||
| 2010-03-31 | $10.00M 10-Q · filed 2011-05-05 | |||
| 2009-12-31 | $31.00M 10-K · filed 2011-02-17 | |||
| 2008-12-31 | $4.00M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |